Pharmafile Logo
Pharmafocus logo
Advanced Search

Macugen

Showing 3 posts of 3 posts found.

FDA warns Gilead over contamination risks at California facility

October 25, 2010
Manufacturing and Production AmBisome, Cayston, FDA, Gilead, Macugen, Viread, manufacturing compliance, pharma manufacturing

Gilead Sciences has been sent a warning letter from the FDA after failing to rectify problems at a facility used to …

News

NICE to re-think blindness drugs decision

August 9, 2007
Sales and Marketing AMD, Lucentis, Macugen, NICE

NICE will delay issuing final guidance on two blindness drugs after an unprecedented patient outcry over its decision to block …

News

NICE set to block blindness drugs

June 15, 2007
Sales and Marketing AMD, Lucentis, Macugen, NICE

Most patients in England and Wales will be denied access to drugs for the leading cause of sight loss if …

News
The Gateway to Local Adoption Series

Latest content

Evotec and Bayer announce new kidney disease study

December 11, 2025

Actithera appoints Darshan Dalal as Chief Medical Officer

December 11, 2025

Pace appoints Ken Beyer as CEO

December 10, 2025

EpilepsyGTx raises $33m for focal refractory epilepsy gene therapy

December 10, 2025

Breast Cancer Now study to explore personalised drug doses

December 9, 2025